A Third Dose of an Inactivated Vaccine Dramatically Increased the Levels and Decay Times of Anti-SARS-CoV-2 Antibodies, but Disappointingly Declined Again: A Prospective, Longitudi...

por Liang, Xian-Ming, Xu, Qiu-Yan, Jia, Zhi-Juan, Wu, Meng-Juan, Liu, Yan-Yun, Lin, Li-Rong, Liu, Li-Li, Yang, Tian-Ci
Publicado 2022

Is the fourth COVID-19 vaccine dose urgently needed? Revelation from a prospective cohort study

por Xu, Qiu-Yan, Li, Qiu-Ling, Jia, Zhi-Juan, Wu, Meng-Juan, Liu, Yan-Yun, Lin, Li-Rong, Liu, Li-Li, Yang, Tian-Ci
Publicado 2022

Developing new COVID-19 vaccine against the variants is urgently needed rather than boosters: A longitudinal cohort study

por Xu, Qiu-Yan, Zheng, Xin-Qi, Jia, Zhi-Juan, Wu, Meng-Juan, Liu, Yan-Yun, Liu, Li-Li, Lin, Li-Rong, Yang, Tian-Ci
Publicado 2023

Response and Duration of Serum Anti-SARS-CoV-2 Antibodies After Inactivated Vaccination Within 160 Days

por Xu, Qiu-Yan, Xue, Jian-Hang, Xiao, Yao, Jia, Zhi-Juan, Wu, Meng-Juan, Liu, Yan-Yun, Li, Wei-Li, Liang, Xian-Ming, Yang, Tian-Ci
Publicado 2021

Anti-SARS-CoV-2 IgM Secondary Response Was Suppressed by Preexisting Immunity in Vaccinees: A Prospective, Longitudinal Cohort Study over 456 Days

por Xu, Qiu-Yan, Xie, Lin, Zheng, Xin-Qi, Liang, Xian-Ming, Jia, Zhi-Juan, Liu, Yan-Yun, Liang, Xiao-Yu, Liu, Li-Li, Yang, Tian-Ci, Lin, Li-Rong
Publicado 2023